Immuneering (IMRX) Other Operating Expenses (2022 - 2026)

Immuneering's Other Operating Expenses history runs 5 years deep, the most recent figure standing at $7317.0 for Q1 2026.

• In Q1 2026, Other Operating Expenses changed 0.0% year-over-year to $7317.0; the TTM figure through Mar 2026 stood at $29268.0 (changed 0.0% YoY), while the FY2025 annual figure was $29267.0, changed 0.0% from the prior year.
• Other Operating Expenses was $7317.0 for Q1 2026 at Immuneering, roughly flat from $7317.0 in the prior quarter.
• In the past five years, Other Operating Expenses ranged from a high of $8103.0 in Q1 2022 to a low of $7316.0 in Q4 2022.
• Historically, Other Operating Expenses has averaged $7363.2 across 5 years, with a median of $7317.0 in 2022.
• Biggest YoY gain for Other Operating Expenses was 0.01% in 2023; the steepest drop was 9.7% in 2023.
• A 5-year view of Other Operating Expenses shows it stood at $7316.0 in 2022, then gained by 0.01% to $7317.0 in 2023, then changed by 0.0% to $7317.0 in 2024, then changed by 0.0% to $7317.0 in 2025, then changed by 0.0% to $7317.0 in 2026.
• The last three Other Operating Expenses figures came in at $7317.0 (Q1 2026), $7317.0 (Q4 2025), and $7317.0 (Q3 2025), per Business Quant data.